# RTB Digital, Inc.: financial statements, quarterly RTB · Nasdaq · CIK 1419275 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rtb.md) · [Financials](/companies/rtb/financials.md) · [Filings](/companies/rtb/filings.md) · [Insiders](/companies/rtb/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rtb/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [17.5](/filings/0001185185-24-001121.md) | [22.2 d](/filings/0001185185-25-000244.md) | [16.8](/filings/0001185185-25-000525.md) | [3.0](/filings/0001185185-25-000998.md) | [2.8](/filings/0001185185-25-001745.md) | [2.7 d](/filings/0001185185-26-001363.md) | [2.8](/filings/0001185185-26-001861.md) | [0.5](/filings/0001185185-26-004069.md) | [2.8](/filings/0001185185-25-001745.md) | [2.8 d](/filings/0001185185-26-001363.md) | [2.5](/filings/0001185185-26-001861.md) | [2.3](/filings/0001185185-26-004069.md) | | Cost of revenue | $m | [10.8](/filings/0001185185-24-001121.md) | [14.5 d](/filings/0001185185-25-000244.md) | [9.7](/filings/0001185185-25-000525.md) | [1.8](/filings/0001185185-25-000998.md) | [1.8](/filings/0001185185-25-001745.md) | [1.6 d](/filings/0001185185-26-001363.md) | [1.4](/filings/0001185185-26-001861.md) | [0.2](/filings/0001185185-26-004069.md) | [1.4](/filings/0001185185-25-001745.md) | [1.5 d](/filings/0001185185-26-001363.md) | [1.4](/filings/0001185185-26-001861.md) | [1.5](/filings/0001185185-26-004069.md) | | Gross profit | $m | [6.7](/filings/0001185185-24-001121.md) | [7.8 d](/filings/0001185185-25-000244.md) | [7.0](/filings/0001185185-25-000525.md) | [1.1](/filings/0001185185-25-000998.md) | [1.1](/filings/0001185185-25-001745.md) | [1.0 d](/filings/0001185185-26-001363.md) | [1.4](/filings/0001185185-26-001861.md) | [0.3](/filings/0001185185-26-004069.md) | [1.4](/filings/0001185185-25-001745.md) | [1.3 d](/filings/0001185185-26-001363.md) | [1.1](/filings/0001185185-26-001861.md) | [0.9](/filings/0001185185-26-004069.md) | | Research and development | $m | [1.3](/filings/0001185185-24-001121.md) | [1.3 d](/filings/0001185185-25-000244.md) | [1.4](/filings/0001185185-25-000525.md) | [0.8](/filings/0001185185-25-000998.md) | [0.8](/filings/0001185185-25-001745.md) | [0.8 d](/filings/0001185185-26-001363.md) | [0.4](/filings/0001185185-26-001861.md) | [0.1](/filings/0001185185-26-004069.md) | [(0.2)](/filings/0001185185-25-001745.md) | [0.2 d](/filings/0001185185-26-001363.md) | [0.1](/filings/0001185185-26-001861.md) | [0.3](/filings/0001185185-26-004069.md) | | Operating income | $m | [(2.4)](/filings/0001185185-24-001121.md) | [(2.8) d](/filings/0001185185-25-000244.md) | [(1.9)](/filings/0001185185-25-000525.md) | [(13.3)](/filings/0001185185-25-000998.md) | [(3.7)](/filings/0001185185-25-001745.md) | [(6.8) d](/filings/0001185185-26-001363.md) | [(4.4)](/filings/0001185185-26-001861.md) | [(0.6)](/filings/0001185185-26-004069.md) | [(1.8)](/filings/0001185185-25-001745.md) | [(3.7) d](/filings/0001185185-26-001363.md) | [(3.0)](/filings/0001185185-26-001861.md) | [(8.9)](/filings/0001185185-26-004069.md) | | Interest expense | $m | [4.2](/filings/0001185185-23-001176.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [0.1](/filings/0001185185-24-001121.md) | [0.2 d](/filings/0001185185-25-000244.md) | [0.2](/filings/0001185185-25-000525.md) | [0.2](/filings/0001185185-25-000998.md) | [0.5](/filings/0001185185-25-001745.md) | [(0.2) d](/filings/0001185185-26-001363.md) | [0.1](/filings/0001185185-26-001861.md) | [0.0](/filings/0001185185-26-004069.md) | [0.0](/filings/0001185185-25-001745.md) | [0.0 d](/filings/0001185185-26-001363.md) | [0.0](/filings/0001185185-26-001861.md) | [0.0](/filings/0001185185-26-004069.md) | | Net income | $m | [(3.1)](/filings/0001185185-24-001121.md) | [(30.0) d](/filings/0001185185-25-000244.md) | [(2.7)](/filings/0001185185-25-000525.md) | [(12.1)](/filings/0001185185-25-000998.md) | [(5.2)](/filings/0001185185-25-001745.md) | [(6.9) d](/filings/0001185185-26-001363.md) | [(0.6)](/filings/0001185185-26-004069.md) | [(0.1)](/filings/0001185185-26-004069.md) | [(2.0)](/filings/0001185185-25-001745.md) | [(4.4) d](/filings/0001185185-26-001363.md) | [(4.8)](/filings/0001185185-26-004069.md) | [(9.6)](/filings/0001185185-26-004069.md) | | Diluted EPS | $ per share | [(0.60)](/filings/0001185185-24-001121.md) | not reported | [(0.45)](/filings/0001185185-25-000525.md) | [(1.88)](/filings/0001185185-25-000998.md) | [(0.76)](/filings/0001185185-25-001745.md) | not reported | [(11.67)](/filings/0001185185-26-001861.md) | [(0.04)](/filings/0001185185-26-004069.md) | [(0.07)](/filings/0001185185-25-001745.md) | not reported | [(2.67)](/filings/0001185185-26-001861.md) | [(1.24)](/filings/0001185185-26-004069.md) | | Basic EPS | $ per share | [(0.60)](/filings/0001185185-24-001121.md) | not reported | [(0.45)](/filings/0001185185-25-000525.md) | [(1.88)](/filings/0001185185-25-000998.md) | [(0.76)](/filings/0001185185-25-001745.md) | not reported | [(11.67)](/filings/0001185185-26-001861.md) | [(0.04)](/filings/0001185185-26-004069.md) | [(0.07)](/filings/0001185185-25-001745.md) | not reported | [(2.67)](/filings/0001185185-26-001861.md) | [(1.24)](/filings/0001185185-26-004069.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [15.8](/filings/0001185185-23-001176.md) | [12.2](/filings/0001185185-25-000244.md) | [10.5](/filings/0001185185-24-000500.md) | [6.4](/filings/0001185185-24-000791.md) | [4.3](/filings/0001185185-24-001121.md) | [2.6](/filings/0001185185-26-001363.md) | [3.0](/filings/0001185185-25-000525.md) | [0.2](/filings/0001185185-25-000998.md) | [1.2](/filings/0001185185-25-001745.md) | [0.5](/filings/0001185185-26-004069.md) | [5.5](/filings/0001185185-26-001861.md) | [0.5](/filings/0001185185-26-004069.md) | | Current assets | $m | [80.3](/filings/0001185185-23-001176.md) | [89.9](/filings/0001185185-25-000244.md) | [94.3](/filings/0001185185-24-000500.md) | [79.5](/filings/0001185185-24-000791.md) | [95.7](/filings/0001185185-24-001121.md) | [95.4](/filings/0001185185-26-001363.md) | [79.8](/filings/0001185185-25-000525.md) | [16.6](/filings/0001185185-25-000998.md) | [19.8](/filings/0001185185-25-001745.md) | [11.7](/filings/0001185185-26-004069.md) | [9.3](/filings/0001185185-26-001861.md) | [15.1](/filings/0001185185-26-004069.md) | | Total assets | $m | [120](/filings/0001185185-23-001176.md) | [129](/filings/0001185185-25-000244.md) | [132](/filings/0001185185-24-000500.md) | [109](/filings/0001185185-24-000791.md) | [127](/filings/0001185185-24-001121.md) | [122](/filings/0001185185-26-001363.md) | [108](/filings/0001185185-25-000525.md) | [20.6](/filings/0001185185-25-000998.md) | [23.4](/filings/0001185185-25-001745.md) | [28.5](/filings/0001185185-26-004069.md) | [9.9](/filings/0001185185-26-001861.md) | [44.1](/filings/0001185185-26-004069.md) | | Current liabilities | $m | [73.2](/filings/0001185185-23-001176.md) | [85.5](/filings/0001185185-25-000244.md) | [91.1](/filings/0001185185-24-000500.md) | [79.7](/filings/0001185185-24-000791.md) | [100](/filings/0001185185-24-001121.md) | [104](/filings/0001185185-26-001363.md) | [104](/filings/0001185185-25-000525.md) | [24.7](/filings/0001185185-25-000998.md) | [24.0](/filings/0001185185-25-001745.md) | [1.9](/filings/0001185185-26-004069.md) | [8.9](/filings/0001185185-26-001861.md) | [11.0](/filings/0001185185-26-004069.md) | | Total liabilities | $m | [138](/filings/0001185185-23-001176.md) | [105](/filings/0001185185-25-000244.md) | [111](/filings/0001185185-24-000500.md) | [100](/filings/0001185185-24-000791.md) | [121](/filings/0001185185-24-001121.md) | [124](/filings/0001185185-26-001363.md) | [111](/filings/0001185185-25-000525.md) | [27.5](/filings/0001185185-25-000998.md) | [26.6](/filings/0001185185-25-001745.md) | [1.9](/filings/0001185185-26-004069.md) | [10.9](/filings/0001185185-26-001861.md) | [13.7](/filings/0001185185-26-004069.md) | | Long-term debt | $m | [61.5](/filings/0001185185-23-001176.md) | [15.9](/filings/0001185185-25-000244.md) | [16.8](/filings/0001185185-24-000500.md) | [17.4](/filings/0001185185-24-000791.md) | [17.7](/filings/0001185185-24-001121.md) | [17.4](/filings/0001185185-25-000525.md) | [4.6](/filings/0001185185-25-000525.md) | not reported | not reported | [0.0](/filings/0001185185-26-004069.md) | not reported | [0.6](/filings/0001185185-26-004069.md) | | Current portion of debt | $m | [0.0](/filings/0001185185-23-001176.md) | [0.0](/filings/0001185185-25-000244.md) | [0.0](/filings/0001185185-24-000500.md) | [0.0](/filings/0001185185-24-000791.md) | [0.0](/filings/0001185185-24-001121.md) | [0.0](/filings/0001185185-25-000525.md) | [15.0](/filings/0001185185-25-000525.md) | not reported | not reported | [0.0](/filings/0001185185-26-004069.md) | not reported | [0.0](/filings/0001185185-26-004069.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(24.7)](/filings/0001185185-24-001121.md) | [23.5](/filings/0001185185-26-001363.md) | [20.5](/filings/0001185185-25-001745.md) | [10.0](/filings/0001185185-25-001745.md) | [6.3](/filings/0001185185-25-001745.md) | [(0.6)](/filings/0001185185-26-004069.md) | [(1.0)](/filings/0001185185-26-004069.md) | [(1.1)](/filings/0001185185-26-004069.md) | [(3.2)](/filings/0001185185-25-001745.md) | [26.6](/filings/0001185185-26-004069.md) | [22.0](/filings/0001185185-26-004069.md) | [30.3](/filings/0001185185-26-004069.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [4.5 d](/filings/0001185185-24-001121.md) | [5.6 d](/filings/0001185185-25-000244.md) | [15.5](/filings/0001185185-25-000525.md) | [(12.8) d](/filings/0001185185-25-000998.md) | [16.4 d](/filings/0001185185-25-001745.md) | [2.1 d](/filings/0001185185-26-001363.md) | [(15.6)](/filings/0001185185-26-001861.md) | [14.9 d](/filings/0001185185-26-004069.md) | [(5.6) d](/filings/0001185185-25-001745.md) | [(16.8) d](/filings/0001185185-26-001363.md) | [(2.1)](/filings/0001185185-26-001861.md) | [(3.1) d](/filings/0001185185-26-004069.md) | | Capital expenditure | $m | [0.1 d](/filings/0001185185-24-001121.md) | [0.0 d](/filings/0001185185-25-000244.md) | [0.0](/filings/0001185185-25-000525.md) | [(0.0) d](/filings/0001185185-25-000998.md) | [0.0 d](/filings/0001185185-25-001745.md) | [0.0 d](/filings/0001185185-26-001363.md) | [0.0](/filings/0001185185-26-001861.md) | [(0.0) d](/filings/0001185185-26-004069.md) | [0.1 d](/filings/0001185185-25-001745.md) | [0.0 d](/filings/0001185185-26-001363.md) | [0.0](/filings/0001185185-26-001861.md) | [0.0 d](/filings/0001185185-26-004069.md) | | Share repurchases | $m | [0.0 d](/filings/0001185185-24-001121.md) | not reported | not reported | not reported | [0.0 d](/filings/0001185185-24-001121.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2018 (2018-03-31) | Q2 FY2018 (2018-06-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [14.4](/filings/0001185185-18-000963.md) | [140](/filings/0001185185-19-000347.md) | [5.1](/filings/0001185185-24-000791.md) | [5.2](/filings/0001185185-24-001121.md) | [6.0](/filings/0001185185-25-000525.md) | [6.4](/filings/0001185185-25-000998.md) | [6.8](/filings/0001185185-25-001745.md) | [0.2](/filings/0001185185-26-001861.md) | [3.3](/filings/0001185185-26-004069.md) | [29.8](/filings/0001185185-25-001745.md) | [1.2](/filings/0001185185-26-001861.md) | [7.7](/filings/0001185185-26-004069.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 14,008,209 at 2026-08-13, from the cover of the [10-Q/A filed 2026-09-16](/filings/0001185185-26-004069.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.